As of 2025-11-04, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (37.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.50 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -186.0%.
The range of the Relative Valuation is (28.12) - (50.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 12.8x | 8.8x |
| Forward P/E multiples | 7.2x - 13.3x | 10.2x |
| Fair Price | (28.12) - (50.34) | (37.40) |
| Upside | -164.6% - -215.7% | -186.0% |
| Date | P/E |
| 2025-10-31 | -11.08 |
| 2025-10-30 | -11.02 |
| 2025-10-29 | -10.92 |
| 2025-10-28 | -10.71 |
| 2025-10-27 | -11.29 |
| 2025-10-24 | -10.44 |
| 2025-10-23 | -10.21 |
| 2025-10-22 | -10.30 |
| 2025-10-21 | -10.91 |
| 2025-10-20 | -10.81 |
| 2025-10-17 | -10.59 |
| 2025-10-16 | -10.77 |
| 2025-10-15 | -11.24 |
| 2025-10-14 | -11.22 |
| 2025-10-13 | -11.31 |
| 2025-10-10 | -11.44 |
| 2025-10-09 | -11.65 |
| 2025-10-08 | -11.31 |
| 2025-10-07 | -10.82 |
| 2025-10-06 | -10.61 |
| 2025-10-03 | -10.41 |
| 2025-10-02 | -10.57 |
| 2025-10-01 | -10.60 |
| 2025-09-30 | -10.61 |
| 2025-09-29 | -11.08 |
| 2025-09-26 | -11.69 |
| 2025-09-25 | -9.14 |
| 2025-09-24 | -8.96 |
| 2025-09-23 | -9.13 |
| 2025-09-22 | -8.59 |
| 2025-09-19 | -8.64 |
| 2025-09-18 | -9.04 |
| 2025-09-17 | -8.71 |
| 2025-09-16 | -8.68 |
| 2025-09-15 | -8.60 |
| 2025-09-12 | -8.66 |
| 2025-09-11 | -8.59 |
| 2025-09-10 | -8.91 |
| 2025-09-09 | -9.29 |
| 2025-09-08 | -8.95 |
| 2025-09-05 | -9.07 |
| 2025-09-04 | -8.72 |
| 2025-09-03 | -8.82 |
| 2025-09-02 | -8.48 |
| 2025-08-29 | -7.89 |
| 2025-08-28 | -7.81 |
| 2025-08-27 | -7.74 |
| 2025-08-26 | -7.88 |
| 2025-08-25 | -7.66 |
| 2025-08-22 | -7.87 |